Unavailable
Unavailable
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/1/2024 | $125.00 → $114.00 | Buy → Neutral | Citigroup |
2/9/2024 | $122.00 → $105.00 | Hold → Buy | HSBC Securities |
2/1/2024 | $108.00 | Buy | Citigroup |
1/10/2024 | Outperform → Peer Perform | Wolfe Research | |
9/15/2023 | $122.00 | Hold | HSBC Securities |
6/22/2023 | $138.00 | Buy | ROTH MKM |
4/14/2023 | $120.00 | Outperform | BMO Capital Markets |
2/9/2023 | $127.00 → $115.00 | Outperform → Neutral | Robert W. Baird |
- Reuters Citing Sources
- Bloomberg
4 - Bunge Global SA (0001996862) (Issuer)
4 - Bunge Global SA (0001996862) (Issuer)
4 - Bunge Global SA (0001996862) (Issuer)
8-K - Bunge Global SA (0001996862) (Filer)
424B3 - Bunge Global SA (0001996862) (Filer)
S-3ASR - Bunge Global SA (0001996862) (Filer)
SC 13G/A - Bunge Global SA (0001996862) (Subject)
SC 13G/A - BUNGELTD (0001144519) (Subject)
SC 13G/A - BUNGELTD (0001144519) (Subject)
Bunge Global SA (NYSE:BG) today reported second quarter 2024 results. Q2 GAAP diluted EPS of $0.48 vs. $4.09 in the prior year; $1.73 vs. $3.72 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences Lower Agribusiness results reflect a more balanced global supply environment Refined and Specialty Oils performed well, but results were down from a strong prior year Excellent progress on Viterra integration planning and other strategic priorities including the announced sale of our interest in the sugar & bioenergy joint venture Updating adjusted full-year EPS outlook to approximately $9.25 Overview Greg Heckman, Bunge's Chief Executi
Bunge Global SA (NYSE:BG) will announce its results for the quarter ended June 30, 2024, on Wednesday, July 31, 2024, prior to the market opening. The Company's management will also host a conference call at 7:00 a.m. Central Time to discuss the results. A slide presentation to accompany the discussion will be posted on www.bunge.com. To access the webcast, go to "Events & Presentations" under "News & Events" in the "Investor Center" section of the company's website. Select "Q2 2024 Bunge Global SA Conference Call" and follow the prompts. Please go to the website at least 15 minutes prior to the call to register and download any necessary audio software. To listen to the call, please di
Shareholders of Bunge Global SA (NYSE:BG) approved a cash dividend in the amount of $2.72 per share, payable in four equal installments of $0.68, at the company's 2024 Annual General Meeting held in Switzerland today. The dividends will be paid as indicated below: Bunge Quarter, Fiscal Year Payment Date Record Date Amount 2nd Quarter, Fiscal Year 2024 June 3, 2024 May 20, 2024 $0.68 3rd Quarter, Fiscal Year 2024 September 2, 2024 August 19, 2024 $0.68 4th Quarter, Fiscal Year 2024 December 2, 2024 November 18, 2024 $0.68 1st Quarter, Fiscal Year 2025 Ma
Citigroup downgraded Bunge from Buy to Neutral and set a new price target of $114.00 from $125.00 previously
HSBC Securities upgraded Bunge from Hold to Buy and set a new price target of $105.00 from $122.00 previously
Citigroup initiated coverage of Bunge with a rating of Buy and set a new price target of $108.00
Bunge Limited (NYSE:BG) today announced that Eliane Aleixo Lustosa de Andrade has been appointed to its Board of Directors, effective November 15, 2022. Aleixo Lustosa most recently served as Managing Director at the Brazilian Development Bank ("BNDES"), National Bank for Economic and Social Development, where she was responsible for capital markets and the execution of the Brazilian Privatization Program. Earlier in her career, she was the Chief Financial Officer of LLX Logística S.A. (currently Prumo Logística S.A.), Vice President of Finance and Control of Grupo Abril S.A., Executive Director of Globex Utilidades S.A. and Chief Investment Officer of the Petrobras' Employee Pension Fund.
Bunge Limited (NYSE:BG) today announced that Michael Kobori and Kenneth Simril have been appointed to its Board of Directors, effective October 25, 2021. Kobori is currently the Chief Sustainability Officer at Starbucks Coffee Company, a position he has held since 2020. Previously, Kobori was with Levi Strauss & Co. where he served as Vice President, Sustainability from 2007 to 2020 and Director, Global Code of Conduct from 2001 to 2006. Prior to that, he was with The Asia Foundation, where he supported human rights and economic development in Bangladesh, Thailand and Vietnam. Simril is the former President and Chief Executive Officer of Fleischmann's Ingredients, a position he held from
Bunge Global SA (NYSE:BG) (the "Company" or "Bunge") today announced that Bunge Limited Finance Corp., its wholly owned finance subsidiary, has successfully priced a public offering of $2.0 billion aggregate principal amount, comprised of three tranches of senior unsecured notes (collectively, the "Senior Notes"), as follows: $400 million aggregate principal amount of 4.100% Senior Notes due 2028; $800 million aggregate principal amount of 4.200% Senior Notes due 2029; and $800 million aggregate principal amount of 4.650% Senior Notes due 2034. The Senior Notes will be fully and unconditionally guaranteed by Bunge Global SA on a senior unsecured basis. The offering was made pursuant
Bunge Global SA (NYSE:BG) ("Bunge"), today announced that in connection with its pending acquisition (the "Business Combination") of Viterra Limited ("Viterra"), Bunge's wholly-owned subsidiary, Bunge Limited Finance Corp. ("BLFC") has commenced offers to exchange (each an "Exchange Offer" and, collectively the "Exchange Offers") any and all outstanding 2.000% Notes due 2026 (the "Existing Viterra 2026 Notes"), 4.900% Notes due 2027 (the "Existing Viterra 2027 Notes"), 3.200% Notes due 2031 (the "Existing Viterra 2031 Notes"), and 5.250% Notes due 2032 (the "Existing Viterra 2032 Notes"), each series as issued by Viterra Finance B.V. ("VFBV") and guaranteed by Viterra and Viterra B.V., for
USA News Group Commentary Issued on behalf of BioVaxys Technology Corp. VANCOUVER, BC, Aug. 19, 2024 /PRNewswire/ -- USA News Group – How we take care of the planet, and the food we eat is rapidly shifting. Back in May, the World Economic Forum addressed how countries are redefining their bioeconomy for the future, with each aiming for sustainable solutions. NGOs around the world are calling for urgent action to accelerate nature-based solutions to tackle global challenges, while the World Bank is encouraging sustainable agriculture, not an end to farming. Behind the scenes, several biotech firms are working on solutions that can help foster these types of goals, including BioVaxys Technolog